Also trades as: AFT.NZ (NZE) · $vol 0M
AFP.AX ASX
AFT Pharmaceuticals Limited
1W: +0.3%
1M: -8.2%
3M: +14.6%
YTD: +6.8%
1Y: +43.8%
3Y: +12.0%
5Y: +52.6%
A$3.50 ($2.43)
+0.05 (+1.45%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$219M
+28.7% ▲
5Y CAGR: +15.8%
Total Liabilities
$109M
+49.5% ▲
5Y CAGR: +9.7%
Shareholders Equity
$111M
+13.8% ▲
5Y CAGR: +24.9%
Cash & Investments
$10M
-7.2% ▼
5Y CAGR: +26.3%
Total Debt
$55M
+81.7% ▲
5Y CAGR: +5.2%
Net Debt
$44M
+134.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $8M | $5M | $12M | $11M | $10M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $8M | $5M | $12M | $11M | $10M |
| Net Receivables | $30M | $40M | $41M | $43M | $65M |
| Inventory | $34M | $42M | $49M | $48M | $75M |
| Other Current Assets | $100K | $736K | $408K | $192K | $0 |
| Total Current Assets | $78M | $95M | $106M | $108M | $150M |
| Property, Plant & Equip. | $3M | $3M | $4M | $3M | $3M |
| Goodwill & Intangibles | $16M | $16M | $17M | $58M | $65M |
| Long-Term Investments | $17M | $15M | $0 | $0 | $0 |
| Other Non-Current Assets | -$19M | -$20M | $39M | $0 | $0 |
| Total Non-Current Assets | $19M | $20M | $60M | $61M | $69M |
| Total Assets | $127M | $148M | $165M | $170M | $219M |
| — Liabilities — | |||||
| Accounts Payable | $12M | $22M | $25M | $25M | $30M |
| Short-Term Debt | $4M | $2M | $0 | $1M | $13M |
| Deferred Revenue | -$5M | -$3M | $0 | $0 | $0 |
| Other Current Liabilities | $2M | $487K | $13M | $8M | $15M |
| Total Current Liabilities | $29M | $40M | $46M | $43M | $67M |
| Long-Term Debt | $33M | $32M | $28M | $26M | $39M |
| Other Non-Current Liab. | -$3M | -$3M | $0 | $0 | $0 |
| Total Non-Current Liabilities | $33M | $32M | $31M | $29M | $42M |
| Total Liabilities | $65M | $75M | $77M | $73M | $109M |
| — Equity — | |||||
| Common Stock | $81M | $81M | $78M | $78M | $79M |
| Retained Earnings | -$16M | -$5M | $9M | $20M | $33M |
| Accumulated OCI | -$3M | $226K | $298K | -$142K | -$344K |
| Total Stockholders Equity | $62M | $73M | $88M | $98M | $111M |
| Total Liabilities & Equity | $127M | $148M | $165M | $170M | $219M |
| — Key Metrics — | |||||
| Total Debt | $41M | $38M | $32M | $30M | $55M |
| Net Debt | $33M | $33M | $20M | $19M | $44M |
| Total Investments | $17M | $15M | $0 | $0 | $0 |